These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7646765)
1. p53 mutation without allelic loss and absence of mdm-2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters. Okita S; Tsutsumi M; Onji M; Konishi Y Mol Carcinog; 1995 Aug; 13(4):266-71. PubMed ID: 7646765 [TBL] [Abstract][Full Text] [Related]
2. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related]
5. Characterization of three cloned cell lines from a N-nitrosobis(2-hydroxypropyl)amine-induced transplantable hamster pancreatic ductal adenocarcinoma. Mori T; Tsutsumi M; Noguchi O; Horiguchi K; Hohnoki K; Okita S; Suzuki F; Konishi Y Int J Pancreatol; 1994; 16(2-3):171-7. PubMed ID: 7868943 [TBL] [Abstract][Full Text] [Related]
6. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma. Soslow RA; Altorki NK; Yang G; Xie D; Yang CS Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Fujii H; Egami H; Chaney W; Pour P; Pelling J Mol Carcinog; 1990; 3(5):296-301. PubMed ID: 2173932 [TBL] [Abstract][Full Text] [Related]
8. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044 [TBL] [Abstract][Full Text] [Related]
9. K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines. Erill N; Cuatrecasas M; Sancho FJ; Farré A; Pour PM; Lluís F; Capellá G Am J Pathol; 1996 Oct; 149(4):1333-9. PubMed ID: 8863680 [TBL] [Abstract][Full Text] [Related]
10. p53 mutations and MDM-2 amplification in renal cell cancers. Imai Y; Strohmeyer TG; Fleischhacker M; Slamon DJ; Koeffler HP Mod Pathol; 1994 Sep; 7(7):766-70. PubMed ID: 7824511 [TBL] [Abstract][Full Text] [Related]
11. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas. Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877 [TBL] [Abstract][Full Text] [Related]
12. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters. Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat. Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the p53 and MDM-2 gene in acute myeloid leukemia. Seliger B; Papadileris S; Vogel D; Hess G; Brendel C; Störkel S; Ortel J; Kolbe K; Huber C; Huhn D; Neubauer A Eur J Haematol; 1996 Sep; 57(3):230-40. PubMed ID: 8898928 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma. Gorgoulis VG; Rassidakis GZ; Karameris AM; Papastamatiou H; Trigidou R; Veslemes M; Rassidakis AN; Kittas C Mod Pathol; 1996 May; 9(5):544-54. PubMed ID: 8733770 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines. Cheng YT; Li YL; Wu JD; Long SB; Tzai TS; Tzeng CC; Lai MD Mol Carcinog; 1995 Jul; 13(3):173-81. PubMed ID: 7619220 [TBL] [Abstract][Full Text] [Related]
17. The p53 and mdm-2 genes in human testicular germ-cell tumors. Riou G; Barrois M; Prost S; Terrier MJ; Theodore C; Levine AJ Mol Carcinog; 1995 Mar; 12(3):124-31. PubMed ID: 7893365 [TBL] [Abstract][Full Text] [Related]
18. Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas. Ittmann M; Wieczorek R; Heller P; Dave A; Provet J; Krolewski J Am J Pathol; 1994 Aug; 145(2):287-93. PubMed ID: 8053489 [TBL] [Abstract][Full Text] [Related]
19. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas. Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192 [TBL] [Abstract][Full Text] [Related]
20. Activation of K-ras in transplantable pancreatic ductal adenocarcinomas of Syrian golden hamsters. Cerny WL; Mangold KA; Scarpelli DG Carcinogenesis; 1990 Nov; 11(11):2075-9. PubMed ID: 2171798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]